55 results
8-K
CELU
Celularity Inc - Ordinary Shares
22 Feb 24
Departure of Directors or Certain Officers
9:05am
, with Dragasac Limited dated January 12, 2024. As a condition of the SPA, Celularity agreed to implement certain changes to the executive compensation program
424B5
CELU
Celularity Inc - Ordinary Shares
28 Jul 23
Prospectus supplement for primary offering
4:24pm
disclosure obligations regarding executive compensation in this prospectus, our periodic reports and our proxy statements and exemptions from … the requirements of holding a nonbinding advisory vote on executive compensation and any golden parachute payments not previously approved. We will remain
424B3
CELU
Celularity Inc - Ordinary Shares
2 Jun 23
Prospectus supplement
5:00pm
on executive compensation and any golden parachute payments not previously approved. We will remain an emerging growth company until the earliest … registered public accounting firm pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive
424B5
7irx60fr4dyiqm
6 Apr 23
Prospectus supplement for primary offering
9:03pm
424B5
ulq9yexc
15 Sep 22
Prospectus supplement for primary offering
4:06pm
424B5
4jnzmbehmx tk
8 Sep 22
Prospectus supplement for primary offering
8:46am
424B3
o9i17 d4xzjd08
24 Aug 22
Prospectus supplement
4:54pm
424B3
mhkb1vgp1dc 2l68
24 Aug 22
Prospectus supplement
4:52pm
S-3
o5s 6lahk5mz
11 Aug 22
Shelf registration
4:29pm
POS AM
i7ztp9plb8x
11 Aug 22
Prospectus update (post-effective amendment)
4:23pm
POS AM
hpb1fkvyo7bgfgjxbzf
11 Aug 22
Prospectus update (post-effective amendment)
4:20pm
424B3
yrvib30yf
1 Jun 22
Prospectus supplement
4:06pm
424B3
1al5 5wl1o
3 May 22
Prospectus supplement
4:06pm